Zevra Therapeutics, Inc. (ZVRA) Misses Q1 EPS by 10c

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) reported Q1 EPS of ($0.34), $0.10 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Zevra Therapeutics, Inc. (ZVRA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49